1	
	
		04, 2025	
	
		2	
	
		01, 2025	
	
		3	
	
		04, 2024	
	
		23	
	
		03, 2024	
	
		14	
	
		02, 2024	
Lorenza Rimassa et al., Phase II Study of Tivantinib and Cetuximab in Patients With KRAS Wild-type Metastatic Colorectal Cancer With Acquired Resistance to EGFR Inhibitors and Emergence of MET Overexpression: Lesson Learned for Future Trials With EGFR/MET Dual Inhibition
adlitterio663392024-04-10T14:35:43+02:00
	
		16	
	
		05, 2023	
	
		10	
	
		02, 2023	
	
		21	
	
		11, 2022	
	
		1	
	
		09, 2022	
	
		25	
	
		04, 2022